|
1
|
Hirooka Y, Sagara Y, Kishi T and Sunagawa
K: Oxidative stress and central cardiovascular regulation.
Pathogenesis of hypertension and therapeutic aspects. Circ J.
74:827–835. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stocker R and Keaney JF Jr: Role of
oxidative modifications in atherosclerosis. Physiol Rev.
84:1381–1478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki YJ, Jain V, Park AM and Day RM:
Oxidative stress and oxidant signaling in obstructive sleep apnea
and associated cardiovascular diseases. Free Radic Biol and Med.
40:1683–1692. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kumar D and Jugdutt BI: Apoptosis and
oxidants in the heart. J Lab Clin Med. 142:288–297. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu YZ, Huang SH, Tan BK, Sun J, Whiteman
M and Zhu YC: Antioxidants in Chinese herbal medicines: a
biochemical perspective. Nat Prod Rep. 21:478–489. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fingar DC and Blenis J: Target of
rapamycin (TOR): an integrator of nutrient and growth factor
signals and coordinator of cell growth and cell cycle progression.
Oncogene. 23:3151–3171. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Proud CG: The multifaceted role of mTOR in
cellular stress responses. DNA Repair (Amst). 3:927–934. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hornberger TA, Stuppard R, Conley KE, et
al: Mechanical stimuli regulate rapamycin-sensitive signalling by a
phosphoinositide 3-kinase-, protein kinase B- and growth
factor-independent mechanism. Biochem J. 380:795–804. 2004.
View Article : Google Scholar
|
|
9
|
Reiling JH and Sabatini DM: Stress and
mTORture signaling. Oncogene. 25:6373–6383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peterson TR, Laplante M, Thoreen CC, et
al: DEPTOR is an mTOR inhibitor frequently overexpressed in
multiple myeloma cells and required for their survival. Cell.
137:873–886. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vander Haar E, Lee S, Bandhakavi S,
Griffin TJ and Kim DH: Insulin signalling to mTOR mediated by the
Akt/PKB substrate PRAS40. Nat Cell Biol. 9:316–323. 2007.PubMed/NCBI
|
|
12
|
Sofer A, Lei K, Johannessen CM and Ellisen
LW: Regulation of mTOR and cell growth in response to energy stress
by REDD1. Mol Cell Biol. 25:5834–5845. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brugarolas J, Lei K, Hurley RL, et al:
Regulation of mTOR function in response to hypoxia by REDD1 and the
TSC1/TSC2 tumor suppressor complex. Genes Dev. 18:2893–2904. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shoshani T, Faerman A, Mett I, et al:
Identification of a novel hypoxia-inducible factor 1-responsive
gene, RTP801, involved in apoptosis. Mol Cell Biol. 22:2283–2293.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ellisen LW, Ramsayer KD, Johannessen CM,
et al: REDD1, a developmentally regulated transcriptional target of
p63 and p53, links p63 to regulation of reactive oxygen species.
Mol Cell. 10:995–1005. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu S, Liu M, Gu X and Ding F:
Neuroprotective effects of salidroside in the PC12 cell model
exposed to hypoglycemia and serum limitation. Cell Mol Neurobiol.
28:1067–1078. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang J, Liu A, Hou R, et al: Salidroside
protects cardiomyocyte against hypoxia-induced death: a HIF-1
alpha-activated and VEGF-mediated pathway. Eur J Pharmacol.
607:6–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakayama H, Chen X, Baines CP, et al:
Ca2+- and mitochondrial-dependent cardiomyocyte necrosis
as a primary mediator of heart failure. J Clin Invest.
117:2431–2444. 2007.
|
|
19
|
Buss SJ, Muenz S, Riffel JH, et al:
Beneficial effects of mammalian target of rapamycin inhibition on
left ventricular remodeling after myocardial infarction. J Am Coll
Cardiol. 54:2435–2446. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lajoie C, El-Helou V, Proulx C, Clément R,
Gosselin H and Calderone A: Infarct size is increased in female
post-MI rats treated with rapamycin. Can J Physiol Pharmacol.
87:460–470. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Ding W, Sun H, et al: Salidroside
protects PC12 cells from MPP+-induced apoptosis via
activation of the PI3K/Akt pathway. Food Chem Toxicol.
50:2591–2597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu Y, Shi YP, Wu D, et al: Salidroside
protects against hydrogen peroxide-induced injury in cardiac H9c2
cells via PI3K-Akt dependent pathway. DNA Cell Biol. 30:809–819.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
DeYoung MP, Horak P, Sofer A, Sgroi D and
Ellisen LW: Hypoxia regulates TSC1/2-mTOR signaling and tumor
suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev.
22:239–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu L, Cash TP, Jones RG, Keith B,
Thompson CB and Simon MC: Hypoxia-induced energy stress regulates
mRNA translation and cell growth. Mol Cell. 21:521–531. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hernández G, Lal H, Fidalgo M, et al: A
novel cardioprotective p38-MAPK/mTOR pathway. Exp Cell Res.
317:2938–2949. 2011.PubMed/NCBI
|
|
26
|
Wang BH, Shravah J, Luo HL, Raedschelders
K, Chen DD and Ansley DM: Propofol protects against hydrogen
peroxide-induced injury in cardiac H9c2 cells via Akt activation
and Bcl-2 up-regulation. Biochem Biophys Res Commun. 389:105–111.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miyamoto S, Murphy AN and Brown JH: Akt
mediated mitochondrial protection in the heart: metabolic and
survival pathways to the rescue. J Bioenerg Biomembr. 41:169–180.
2009. View Article : Google Scholar : PubMed/NCBI
|
